Skip to content
Webe Honey – Lifestyle
Author:
HDT Bio Corp
HDT Bio Receives ARPA-H GIVE Award to Lead Development of Automated, Point-of-Care Manufacturing for Personalized RNA Medicines
September 15, 2026
A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
July 12, 2026
HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
May 21, 2026